Merck India announced its 10th Merck Bioforum India 2022

Spread the love

Merck India announced its 10^th Merck Bioforum India 2022. The move towards next-generation bioprocessing is real and is happening now. 10^th Merck Bioforum India 2022 is a thought leadership program which is a part of the flagship Asia seminar series that Merck Life Sciences Pvt. Ltd. has been organizing annually. This year’s Bioforum India is being hosted in two different cities in India (on September 8^th, 2022 in Ahemdabad), focusing on Next Generation Bioprocessing for Process Intensification. This is an annual knowledge-sharing platform to build a network of end-users and discuss the evolving future trends of biologics manufacturing processes and technologies, challenges, and process intensification.

The move towards next-generation bioprocessing from process intensification to fully continuous processing is real and is happening now and we are all in it together. While the benefits of next-generation bioprocessing are clear, there are multiple pathways to success and many options across a range of disciplines must be considered. For some applications and biomanufacturers, the focus will be on improving unit operation’s interoperability, for others the goal will be connected or fully continuous processing. Together with our customers and regulators, we strive to accelerate access to biopharmaceuticals for patients worldwide.

Join us for 10^th Merck Bioforum India 2022: Next Generation Bioprocessing for Process Intensification where we will deep drive with industry experts. This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost and risks of navigating the evolving biopharma landscape

We will have renowned industry experts like Dr. Rustom Mody, Senior Vice President & Head R&D Biologics division, Sun Pharmaceutical Industries Ltd., Dr. Praveen Gupta, Senior General Manager, Research & Development, Intas Pharmaceutical Ltd., Dr. Ashish Sahai, Additional Director, Production (viral vaccines), Serum Institute of India Pvt. Ltd., Dr. Ratnesh Jain, Associate Professor, Department of Biological Sciences and Biotechnology, ICT Mumbai along with Merck experts like Dr. Subhasis Banerjee, Principal Application Expert, APAC Bioprocessing, Merck KGaA, Dr. Simone Biel, Senior Regulatory Consultant, Merck KGaA etc.

Take this valuable opportunity to join us and register for this seminar to discuss more on evolving future trends of biologics manufacturing processes and technologies, challenges, and process intensiﬁcation.